Breakthrough in Age-related Macular Degeneration Treatment

by Medindia Content Team on October 10, 2007 at 8:00 PM
Breakthrough in Age-related Macular Degeneration Treatment

Researchers at the University of Pennsylvania School of Medicine have developed the first animal model of age-related macular degeneration (AMD), which could pave the way for better treatments.

Age-related macular degeneration is caused by the development of deposits between the retinal pigment epithelium and its basement membrane, called Bruch's membrane. The material starts as basal deposits and becomes drusen, extracellular deposits of protein and lipids that accumulate and can cause blindness.


In order to prevent the basal deposits from forming, researchers developed an animal model to understand the mechanisms that cause them to form in the first place.

"To better develop treatments for preventing the progression of AMD, we need to understand the real biochemical details of how AMD occurs," said the lead author Eric A. Pierce, MD, PhD, and Associate Professor of Ophthalmology at Penn's K.M Kirby Center for Molecular Ophthalmology.

"To do that, we need a model, and now we have one," he added.

Some forms of macular degeneration are inherited, and one type is thought to be caused by a mutation in the Efemp1 gene.

Researchers created a mouse model of this inherited disorder by introducing the disease-causing mutation into the Efemp1 gene of mice. The resulting Efemp1-mutant mice develop the same basal deposits as people with AMD.

They plan to use the Efemp1-mutant mice to study how basal deposits form and what they are made of. The mice can also be used to test potential treatments to prevent basal deposit formation.

"By making this particular mutant mouse, we've made a model of early macular degeneration that's caused by a mutation we know produces macular degeneration in people," Pierce said.

"We think it's going to be a good model to study the pathogenesis of basal deposits," he added.

AMD is the leading cause of vision loss in elderly people, affecting more than 10 million people in the U.S. and about 50 million worldwide. Although it is a common and debilitating condition, prevention and treatment options are limited because AMD is considered a difficult condition to study.

This is because it develops late in life - patients typically show symptoms of AMD after 60, and the only samples researchers could use for study were from people who died while they had the early stages of AMD, and at that point, the tissue is not useful to study the condition's progression.

Therefore, researchers have now developed a model, which they claim is the first important step in developing treatment for the disease.

The study is published in the October issue of Human Molecular Genetics.

Source: ANI
Font : A-A+



Latest Senior Health News

High Thyroid Hormones Linked to Cognitive Disorders
An elevated presence of thyroid hormones, known as thyrotoxicosis, has been associated with a higher likelihood of cognitive disorders in older adults.
Alarming Rates of Suicidal Ideation Among Elderly Transgenders
Elderly transgenders face a higher risk of suicide due to socio-economic factors with 25% of them giving serious thought to taking their own lives.
Is Improved Deep Sleep the Key to Dementia Prevention?
A decrease of 1% in deep sleep annually for individuals aged 60 and above results in a 27% higher dementia risk.
Cognitive Benefits for Older Adults Through Golf and Walking
In seniors, engaging in a single session of either 18 holes of golf, 6 km of Nordic walking, or 6 km of regular walking was observed to boost cognitive functions.
Could Higher Triglycerides Be the Key to Lower Dementia Risk?
Higher triglycerides linked to slower cognitive decline in various aspects, incl. global function, memory, & more over time.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Breakthrough in Age-related Macular Degeneration Treatment Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests